Key considerations when prescribing midostaurin with a strong CYP3A4 inhibitor

Sdílet
Vložit
  • čas přidán 6. 09. 2024
  • Dr. Perl gives guidance on providing optimal patient therapy when prescribing midostaurin with a strong CYP3A4 inhibitor.
    Join our online communities to begin receiving free continuing medical education (CME) credit today!
    Managing Myeloma: www.managingmye...
    Managing Hodgkin Lymphoma: www.managinghod...
    Managing MDS: www.managingmds...
    Managing AML: www.managingaml...
    Partners in Pancreatic Cancer: www.partnersinp......
    The Practical Oncologist: www.practicalon...

Komentáře •